Life Science Nation and MaRS Collaborate with Johnson & Johnson Innovation, JLABS to Host RESI Conference in Toronto

17 Sep

By Dennis Ford, Founder & CEO, LSN 

Dennis book

BOSTON-September 16, 2015 – Life Science Nation (LSN) and MaRS Discovery District (MaRS) are collaborating with Johnson & Johnson Innovation, JLABS (JLABS) to bring the Redefining Early Stage Investments (RESI) Conference to Toronto on June 23, 2016.

The RESI Conference series brings together fundraising CEOs and early stage investors from around the globe, providing the opportunity for dialogue and relationship building, with the goal of eventual capital allocations.

“MaRS supports over 250 Canadian-grown early stage health technology startups,” said Dr. Zayna Khayat, Lead, MaRS Health. “Our goal is to provide these young emerging ventures with the best connections to investors and industry to help them scale internationally. The Redefining Early Stage Investments (RESI) conference series has a strong track record of attracting global early stage investors. We’re delighted to bring them to MaRS in 2016 to build on the success of our HealthKick conferences and support new technologies that will achieve better health outcomes.”

Johnson & Johnson Innovation, JLABS, MaRS, the Ontario Government, University of Toronto and other collaborators announced last week that JLABS will be opening its first ex-U.S. incubator in Toronto. Called JLABS @ Toronto, the site is expected to open in the Spring of 2016. JLABS @ Toronto, MaRS and RESI will connect cutting-edge health technologies with a broad audience of investors and industry leaders including: angel syndicates, family offices/private wealth firms, corporate venture capitalists, venture philanthropy groups, foundations and endowments, pharmaceutical companies, mid-level private equity firms, government organizations, and venture capital investors.

“The MaRS Centre in Toronto represents the 4th venue for our North American RESI Conference series. Now fundraising CEOs and scientist entrepreneurs can meet investors every 90 days – Boston in September (RESI Boston), San Francisco in January (RESI @ JPM), Houston in April (RESI @ TMCx) and now Toronto in June (RESI on MaRS),” said Dennis Ford, CEO of LSN and creator of the RESI Conference Series. “Fundraising is essentially a numbers game and the entrepreneur needs to get in front of as many investors as possible. Having as many as 20 investor meetings every 90 days can dramatically help with funding in the healthcare arena.”

Speakers and participating health ventures will be announced in early 2016.

About Life Science Nation

Life Science Nation (LSN) accelerates the funding of early stage life science firms through its sourcing platform for private investment and enables CEOs to be more efficient in their capital-raising efforts. LSN owns and operates the Redefining Early Stage Investments (RESI) conference series.

About MaRS Discovery District

MaRS Discovery District in Toronto is the one of the world’s largest urban innovation hubs supporting a new generation of makers and innovators who aim to make the world a better place by creating solutions that address key societal challenges. It is a community that encourages entrepreneurial thinking through education programs and events, and helps start-ups launch, grow and scale. MaRS supports over 1,000 ventures.


PR Contacts: Nono Hu

Marketing/PR Manager, Life Science Nation

(617) 580-5011

Lara Torvi

MaRS Discovery District

(416) 673-8100

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: